The University of Mississippi
School of Pharmacy Department of Medicinal Chemistry

Department of Medicinal Chemistry Seminars


SPRING 2012 Medicinal Chemistry Seminar Series

In TCRC 2066 at 11 am - 12 noon on Tuesdays,

except as noted

 

Date

Lecturer

Affiliation

Title

January 24

NO SEMINAR SCHEDULED

January 31

WELCOME BACK/ORGANIZATIONAL MEETING

February 7

Amer Tarawnah

UM MedChem

Lysine Demethylase Inhibitors

February 14

NO SEMINAR SCHEDULED

February 21

Eric Bow

UM MedChem

Orexin Receptors - Opportunities for drug development

February 28

NO SEMINAR SCHEDULED

March 6

NO SEMINAR SCHEDULED

March 13

SPRING BREAK - No Seminar

March 20

Zarana Chauhan

UM MedChem

Recent Advances in Mineralocorticoid Receptor Antagonists

March 27

Pankaj Pandey

UM MedChem

Bile Acid Receptor Modulators in Metabolic Diseases

March 28, Wednesday
12 noon
TCRC 1000

Marshall Fisher

Director, Mississippi Bureau of Narcotics

Methamphetamine

April 3

Prof. Jacques Poupaert

Catholic University of Louvain, Brussels Belgium, Faculty of Pharmacy and Biomedical Sciences and Louvain Drug Research Institute

Squalene-drug conjugate based nanoparticles: How medicinal chemistry can help design supramolecular architectures

April 10

Prof. S. Michael Owens

Professor and Director, Center for Alcohol and Drug Abuse, and a Wilbur Mills Endowed Chair in Alcohol and Drug Abuse Prevention, Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences

RONALD F. BORNE LECTURE

Title: Therapeutic antibodies for the treatment of addiction – At the interface of chemistry and biology

April 17

Dr. Michael Rogers

 Division Director, National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH)

  2012 JOSEPH SAM DISTINGUISHED ALUMNUS

Title:  TBA

April 24

TBA

 TBA

  TBA

May 1

NO SEMINAR SCHEDULED

 

 

Fall 2011 Medicinal Chemistry Seminar Series

 

Date

Lecturer

Affiliation

Title

August 23

MEDCHEM

---

Organizational Meeting

August 30

ACS DENVER NO SEMINAR

September 6

Dr. Kip Guy
Chair, Chemical Biology & Therapeutics

St. Jude Children's Research Hospital

 

Screening and Synthesis of Antimalarials

September 13

Shuneize Slater

UM MedChem

Tripeptide motifs in biology:  Targets for peptidomimetic design

September 20

CAMPUS EVENT

9AM (Ballroom,The Inn at Ole Miss)

Dr. Roald Hoffman
Nobel Laureate Chemistry
Professor Emeritus, Chemistry & Chemical Biology

Cornell University

The Chemical Imagination at Work in Very Tight Places

September 27

OPEN

 

 

October 4

OPEN

 

 

October 11

Dr. Robert Reynolds
Director, Drug Discovery Technology
Manager, Medicinal Chemistry

Southern Research Institute

Classical NSAID Scaffolds and Chemical Biology

October 18

OPEN

 

 

October 25

AAPS MEETING

November 2, Wednesday at 2pm in NPC 2066

Dr. Keith Mead

Mississippi State University, Department of Chemistry

Focused Studies in Heterocyclic Synthesis

November 8

Rohit Bhat

 UM Medchem

Dissertation Defense

November 15

Walid Alsharif

 UM Medchem

  Improvement in aqueous solubility by disruption of molecular planarity and symmetry

November 25

FALL BREAK

November 29

Brian Morgan

 UM MedChem

 ORP

 

 

Spring 2011 Medicinal Chemistry Seminar Series

In TCRC 2066, at 11 am - 12 noon on Tuesdays, except as noted

 

January 25 – Intro/welcome back

February 1 – Arindam Chatterjee “Saga of the third histamine receptor”

February 8 – Shuneize Slater “The Discovery and Development of 5-HT2C Receptor Agonists for the Treatment of Obesity”

February 15 – Walid Alsharif “Applications of Fluorine in Drug Discovery and Optimization”

February 22 – Cancelled

March 1 – Xiaoning Wang “Direct Renin Inhibitors as a New Therapy for Hypertension”

March 8 – Prashant V. Desai, PhD, Senior Research Scientist, Drug Disposition, Eli Lilly “Integration of In silico - In vitro - In vivo ADMET Models During Early Drug Discovery”

March 22 – Arthur S. Edison, Professor, Biochemistry & Molecular Biology, Director of Chemistry & Biology National High Magnetic Field Laboratory, University of Florida (NCNPR guest) “Chemical Ecology of Nematodes”

April 5 – Ahmed Idris “Nitrile-Containing Pharmaceuticals”

April 19 – Kate Holloway, PhD, Merck & Co., Inc. “Structure-Based Design of Protease Inhibitors”

April 21, 11am (Thursday) – Ronald F. Borne Lecture – Dr. Bruce E. Maryanoff, PhD, Department of Chemistry, The Scripps Research Institute (in TCRC 1000) “Adventures in Drug Discovery: Enzyme Inhibitors, Receptor Antagonists ... and More“

April  26 – Gregory Sawyer, PhD, Associate Professor, Department of Biochemistry and Microbiology, Center for Health Sciences, College of Osteopathic Medicine, Oklahoma State University “Muscarinic Acetylcholine Receptor Trafficking”

May 3 – Frederick T. Chin, PhD, Head of Cyclotron Radiochemistry, Molecular Imaging Program, Stanford University Medical Center

 

 

2010-2011 Borne Lecture Info:

Bruce Maryanoff has been active as a medicinal and organic chemist. He invented TOPAMAX topiramate, a unique sugar sulfamate drug, marketed worldwide for treating epilepsy and migraine, with annual sales >$2 billion. He is an internationally renown expert in drug design and discovery, esp. the application of protein structure-based drug design. Since 1991 he pursued cardiovascular therapeutics, while seeking drugs for pulmonary inflammation, metabolic disorders, and epilepsy. In the past 15 years, his drug research has dealt with structure-based drug design; peptides/peptidomimetics; enzymes inhibitors, esp. serine proteases/kinases; integrin antagonists; ligands for G-protein-coupled receptors. His efforts led to many new chemical entities entering preclinical development, with 13 advancing into human clinical trials. He made seminal contributions to understanding stereochemistry and mechanism of the Wittig reaction; devised novel peptides that self-assemble to mimic native collagen. Maryanoff is an author on 270 scientific publications, including books (Editor), book chapters, review articles. He is an inventor on 100 U.S. patents (issued/pending), presented >150 invited lectures, mentored 11 postdocs. He is Assoc. Editor of ACS Med. Chem. Lett.; organized/edited a special issue of J. Med. Chem. to honor Dr. Paul Janssen; has served on editorial advisory boards for journals and research grant committees. Maryanoff received two American Chemical Society national awards, and the prestigious Smissman Award from the Med. Chem. Division of the ACS; was inducted into the ACS Medicinal Chemistry Hall of Fame in 2008; was elected Fellow of the ACS, Amer. Assoc. for the Advancement of Science, and Royal Society of Chemistry. He retired from Johnson & Johnson in Jan 2010, after 36 years of service, and is now affiliated with The Scripps Research Institute (La Jolla, CA); Pennsylvania Drug Discovery Institute (Doylestown, PA); Institute for Hepatitis and Virus Research.

Look for the seminars to be announced in the departmental social media services (TBA) and on Ole Miss Today.

Fall 2010 Department of Medicinal Chemistry Seminar Series

Tuesdays 11 am - 12 noon (2066 NPC)

Date

Speaker

Title

August 
24

Department of Medicinal Chemistry faculty

Welcome and Introduction to Department

August 
31

 

 

September 7

Khaled Elokely
Graduate Student
Medicinal Chemistry
Ole Miss

“Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic”

September 14

Afeef Husni
Graduate Student
Medicinal Chemistry
Ole Miss

“Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes”

September 21

Ahmed Idris
Graduate Student
Medicinal Chemistry
Ole Miss

“The FGF family: biology,
pathophysiology and therapy”

September 28

David Rotella, Ph.D.
Medicinal Chemistry Consultant and Adjunct Professor of Medicinal Chemistry, U. Mississippi

“A Dual Target Approach for Schizophrenia”

 

October 
5

John Babu, Ph.D.
President
Panvirex LLC

TBA

October 
12

Xaoning Wang
Graduate Student
Medicinal Chemistry
Ole Miss

TBA

October 
19

Timothy A. Blizzard, Ph.D.
Distinguished Senior Investigator
Medicinal Chemistry
Merck Research Labs

“Overcoming bacterial resistance to beta-lactam antibiotics: A tale of two drug discovery programs.” 

October 
26

 

 

November 2

Amit Kalgutkar, Ph.D.
Research Fellow
Pfizer Global R&D

“Chemical Toxicophores: Potential for Trouble”

November 9

 

 

November 16

NO SEMINAR

2010 FIP Pharmaceutical Sciences World Congress/AAPS Annual Meeting; New Orleans

November 23

NO SEMINAR

Fall Break

November 30

NO SEMINAR

2010 joint meeting of the 66th Southwest and 62nd Southeastern Regional Meetings of ACS; New Orleans, LA